Literature DB >> 19480840

CR1 levels and gene polymorphisms exhibit differential association with falciparum malaria in regions of varying disease endemicity.

Swapnil Sinha1, Ganga N Jha, Prerna Anand, Tabish Qidwai, Sudhanshu S Pati, Sanjib Mohanty, Saroj K Mishra, Prajesh K Tyagi, Surya K Sharma, Vimala Venkatesh, Saman Habib.   

Abstract

Complement receptor 1 (CR1/CD35) levels on erythrocytes and related CR1 polymorphisms have been associated with response to falciparum malaria in populations inhabiting malaria-endemic regions. Differences in disease association profiles of its low expression alleles have been observed in populations from different regions of the world. We analyzed the influence of CR1 levels and associated SNPs on susceptibility/resistance to falciparum malaria in Indian populations. Two CR1 SNPs [exon 22 (A/G) and intron 27 (A/T)] define the low expression (L) CR1 allele in populations inhabiting a Plasmodium falciparum-endemic and a nonendemic region of India. Populations of the endemic region have very low red blood cell surface CR1 levels and higher frequencies of the exon 22 and intron 27 mutant L alleles. Whereas low CR1 levels correlated with susceptibility to severe malaria in the nonendemic region, high CR1 levels were associated with manifestation of disease in the endemic region. In addition, the exon 22 L allele was a risk factor for severe malaria in the nonendemic region. Absence of correlation between levels of tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 with CR1 levels in patients with severe disease indicated that RBC CR1 levels in individuals are not the major determinants of pro-inflammatory cytokine release during infection. Our results are interpreted in the context of differences in the pathogenesis of severe malaria in the malaria-endemic and nonendemic region.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19480840     DOI: 10.1016/j.humimm.2009.02.001

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

1.  Use of mosquito preventive measures is associated with increased RBC CR1 levels in a malaria holoendemic area of western Kenya.

Authors:  Christine King; Ping Du; Walter Otieno; José A Stoute
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

Review 2.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

3.  Association of the single-nucleotide polymorphism and haplotype of the complement receptor 1 gene with malaria.

Authors:  Yan Lan; Chuan-Dong Wei; Wen-Cheng Chen; Jun-Li Wang; Chun-Fang Wang; Guo-Gang Pan; Ye-Sheng Wei; Le-Gen Nong
Journal:  Yonsei Med J       Date:  2015-03       Impact factor: 2.759

4.  Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study.

Authors:  Rafal S Sobota; Antoine Dara; Jessica E Manning; Amadou Niangaly; Jason A Bailey; Abdoulaye K Kone; Mahamadou A Thera; Abdoulaye A Djimdé; Guy Vernet; Philippe Leissner; Scott M Williams; Christopher V Plowe; Ogobara K Doumbo
Journal:  Malar J       Date:  2016-03-09       Impact factor: 2.979

5.  Beta-thalassemia minor is associated with IgA nephropathy.

Authors:  Jung Hyun Kang; Bo Rha Park; Kyung Soo Kim; Do Yeun Kim; Hee Jin Huh; Seok Lae Chae; Sung Joon Shin
Journal:  Ann Lab Med       Date:  2013-02-21       Impact factor: 3.464

6.  Complement receptor 1 variants confer protection from severe malaria in Odisha, India.

Authors:  Aditya K Panda; Madhumita Panda; Rina Tripathy; Sarit S Pattanaik; Balachandran Ravindran; Bidyut K Das
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

7.  Increased survival in B-cell-deficient mice during experimental cerebral malaria suggests a role for circulating immune complexes.

Authors:  Rosane B de Oliveira; Jennifer P Wang; Sanjay Ram; Ricardo T Gazzinelli; Robert W Finberg; Douglas T Golenbock
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

Review 8.  Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum.

Authors:  Tabish Qidwai; Farrukh Jamal; Mohd Y Khan; Bechan Sharma
Journal:  Biochem Res Int       Date:  2014-04-23

9.  Red blood cell complement receptor one level varies with Knops blood group, α(+)thalassaemia and age among Kenyan children.

Authors:  D H Opi; S Uyoga; E N Orori; T N Williams; J A Rowe
Journal:  Genes Immun       Date:  2016-02-04       Impact factor: 2.676

10.  CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population.

Authors:  Aditya K Panda; Balachandran Ravindran; Bidyut K Das
Journal:  Lupus Sci Med       Date:  2016-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.